Superworth

Profusa EPS PFSA

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Last 12 months, to Jun 30, 2026
n/m
a quarter missing
Latest quarter, Q2 FY26
−$151.80
Fiscal year 2024
−$22200.00
−2073% on the year before

Profusa's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY26, it was −$151.80.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2024−$22200.00−2073%
FY2023$1125.00−89%
FY2022$10275.00n/a
FY2021n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$151.80n/an/a
Q1 FY26−$205.00n/an/a
Q3 FY25−$5250.00n/a−$35809.78
Q2 FY25−$9100.78n/a−$40234.78
Q1 FY25−$10509.00n/a−$31659.00
Q4 FY24−$10950.00−3020%−$22200.00
Q3 FY24−$9675.00n/a−$10875.00
Q2 FY24−$525.00−150%−$1650.00
Q1 FY24−$1050.00−800%−$75.00
Q4 FY23$375.00−44%$1125.00
Q3 FY23−$450.00−118%$1425.00
Q2 FY23$1050.00−39%$4425.00

Against its peers

Companies in Medical - Instruments & Supplies nearest Profusa's size, closest first, today.

CompanyEPS, 12 months
PFSAProfusan/m
GCTKGlucotrackn/m
VJETFlyte Aviationn/m
BBLGBone Biologics−$1.61
IVFINVO Fertilityn/m
TNONTenon Medical−$25.65
XAIRBeyond Air−$68.40
ADGMAdagio Medical−$1.43
AMIXAutonomix Medicaln/m
NXGLNexgel−$14.20
BJDXBluejay Diagnostics−$8.68
Peer median−$11.44

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Profusa

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.